NCT00218205View on ClinicalTrials.gov

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

June 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Epirubicin

DRUG

Estramustine Phosphate

DRUG

Celecoxib

Trial Locations (1)

07018

RECRUITING

Department of Veterans Affairs NJ Health Care System, East Orange

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Department of Veterans Affairs, New Jersey

FED